Table 1: Patient Demographic and Baseline Characteristics in the PP Population

Structum® (N=348) Chondrosulf® (N=344) All  (N=692)
Sex n (%) Female 234 (67.2) 238 (69.2) 472 (68.2)
Age at screening (years)* Min., Max.] 65.15 (8.59) [49.00, 80.00] 65.09 (8.59) [50.00, 81.00] 65.12 (8.58) [49.00, 81.00]
Weight (kg) 75.71 (13.19) 75.23 (12.38) 75.47 (12.78)
Height (cm) 165.13 (8.30) 164.43 (8.77) 164.78 (8.54)
BMI (kg/m2;)* [1] Min., Max.] 27.67 (3.75) [19.00, 34.00] 27.74 (3.63) [19.00, 34.00] 27.71 (3.69) [19.00, 34.00]
For females, post-menauposal status: yes n (%) 230 (98.3) 235 (98.7) 465 (98.5)
Disease duration (years) 5.58 (5.37) 5.65 (5.30) 5.61 (5.33)
Family history of OA n (%) 51 (15.3) 54 (16.6) 105 (15.9)
Target knee: right n (%) 178 (51.1) 181 (52.6) 359 (51.9)
Effusion in target knee: yes n (%) 17 (4.9) 11 (3.2) 28 (4.0)
OA in the non target knee: yes n (%) 249 (71.6) 267 (77.6) 516 (74.6)
Hip OA: yes n (%) 22 (6.3) 22 (6.4) 44 (6.4)
Cervical spine OA: yes n (%) 71 (20.6) 55 (16.1) 126 (18.3)
Lumbar spine OA: yes n (%) 106 (30.6) 92 (26.9) 198 (28.8)
Hand OA: yes n (%) 35 (10.1) 17 (5.0) 52 (7.5)
Kellgren-Lawrence grade n (%)
  Grade II
  Grade III

244 (70.1)
104 (29.9)

238 (69.2)
106 (30.8)

482 (69.7)
210 (30.3)
Non pharmacological  treatment (target knee) n (%) 13 (3.7) 13 (3.8) 26 (3.8)
Previous IA corticosteroid injection in target knee: yes n (%) 11 (3.2) 8 (2.3) 19 (2.7)
Previous HA injections: yes n (%) 15 (4.3) 11 (3.2) 26 (3.8)

All data are given as mean (sd) or N (%).
* Calculated data ; [1] BMI (kg/m²) = Weight (kg) / Height (m)²
OA = osteoarthritis ; IA = intra-articular ; HA = hyaluronic acid.